Success Metrics

Completion Rate
0%(0/3)
Active Trials
0(0%)
Terminated
3(75%)

Phase Distribution

Ph phase_1
3
75%
Ph not_applicable
1
25%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Terminated(3)
Other(1)

Detailed Status

Terminated3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
0.0%
Most Advanced
Phase 1

Trials by Phase

Phase 13 (75.0%)
N/A1 (25.0%)

Trials by Status

terminated375%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
terminatednot_applicable

Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer

NCT00619515
terminatedphase_1

Stereotactic Radiation Therapy in Treating Patients With Liver Metastases

NCT00938457
terminatedphase_1

Implantation of Markers for the Radiotherapy of Lung Cancer Patients

NCT00856427
unknownphase_1

3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder

NCT01124682

Clinical Trials (4)

Showing 4 of 4 trials
NCT00619515Not Applicable

Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer

Terminated
NCT00938457Phase 1

Stereotactic Radiation Therapy in Treating Patients With Liver Metastases

Terminated
NCT00856427Phase 1

Implantation of Markers for the Radiotherapy of Lung Cancer Patients

Terminated
NCT01124682Phase 1

3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4